COM:NEXIMMUNE
NexImmune
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
neximmune.comcrunchbase
neximmunelinkedin
neximmune-inc.founding date
Jan 01, 2011ipo date
Feb 12, 2021
NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001...Show More